Table 2: CLE performance.
Reference |
Year |
Pathology |
Total no. patients/lesions |
Sensitivity |
Specificity |
Accuracy |
Canto, et al. [40] |
2014 |
EAC |
192 patients; 978 biopsy specimens |
96% |
92% |
93% |
Sharma, et al. [41] |
2011 |
EAC |
101 patients |
68.30% |
87.80% |
|
Pech, et al. [42] |
2008 |
ESCC |
27 patients |
100% |
87% |
95% |
Huang, et al. [43] |
2015 |
ESCC |
52 patients |
95.70% |
90% |
97.80% |
Kitabatake, et al. [44] |
2006 |
Gastric cancer |
27 patients; 57 sites |
82-91% |
98% |